1. 1) Groopman, J.D., Jiaqi, Z, Donahue, P.R., Pikul, A., Lisheng, Z., Jun-shi, C., Wogan, G.N.: Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region. People's Republic of China. Cancer Res, 52, 45-52 (1992)
2. 2) Stern, M.C., Umbach, D.M., Yu, M.C., London, S.J., Zhang, Z.Q., Taylor, J.A.: Hepatitis B, aflatoxin B (1), and p 53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies. Cancer Epidemiol Biomarkers Prev, 10, 617-25 (2001)
3. 3) Morimura, S., Tashiro, F., Ueno, Y.: Establishment and characterization of cell lines (Kagura- 1 and Kagura-2) from aflatoxin B1-induced rat hepatoma. Chem Pharm Bull (Tokyo), 38, 460-463 (1990)
4. 4) Sugiyama, A., Suda, M., Mistuyama, E., Iwatsu, M., Matsuura, K., Ohtsubo, K., Tashiro, F.: Suppression of the neoplastic phenotype of aflatoxin B1 -induced rat hepatoma cells by the retinoblastoma tumor suppressor gene. Mycotoxins, 48, 59-71 (1998)
5. 5) Komiya, Y., Kurabe, N., Katagiri, K., Ogawa, M., Sugiyama, A., Kawasaki, Y., Tashiro, F.: A novel binding factor of 14-3-3β functions as a transcriptional repressor and promotes anchorage-independent growth, tumorigenicity, and metastasis. J Biol Chem, 283, 18753-18764 (2008)